BE Dunning, JE Foley, B Ahren - Diabetologia, 2005 - Springer Abstract Although there is abundant evidence that hyper- glucagonaemia plays a
key role in the development of hy- perglycaemia in type 2 diabetes, efforts to
understand and correct this abnormality have been overshadowed by the ... Cited by 70 - Related articles - BL Direct - All 3 versions
MS Rendell, L Jovanovic - Metabolism, 2006 - Elsevier In healthy individuals, blood glucose levels in the fasting state are maintained
by the continuous basal-level insulin secretion. After a meal, the rise in
postprandial glucose (PPG) is controlled by the rapid pancreatic release of ... Cited by 29 - Related articles - All 12 versions
JL Estall, DJ Drucker - Current pharmaceutical design, 2006 - ingentaconnect.com Abstract: Glucagon and the glucagon-like peptides are derived from a common
proglucagon precursor, and regulate en- ergy homeostasis through interaction
with a family of distinct G protein coupled receptors. Three ... Cited by 26 - Related articles - BL Direct - All 5 versions
S Unniappan, CHS McIntosh, HU Demuth, U … - Diabetologia, 2006 - Springer Page 1. ARTICLE Effects of dipeptidyl peptidase IV on the satiety actions
of peptide YY S. Unniappan & CHS McIntosh & H.-U. Demuth & ... Cited by 18 - Related articles - BL Direct - All 3 versions
IW Campbell, S Mariz - Diabetes research and clinical practice, 2007 - Elsevier Progressive β-cell dysfunction and β-cell failure are fundamental pathogenic
features of type 2 diabetes. Ultimately, the development and continued
progression of diabetes is a consequence of the failure of the β-cell to ... Cited by 13 - Related articles - All 11 versions
MCB Edwards - Annals of Medicine, 2005 - informahealthcare.com Glucagon‐like peptide‐1 (GLP‐1) was first isolated and sequenced twenty
years ago. It has been shown to have many effects in man. GLP‐1 stimulates
insulin secretion, delays gastric emptying, decreases glucagon levels and ... Cited by 11 - Related articles - BL Direct - All 7 versions
JC Levy - DIABETIC MEDICINE-CHICHESTER-, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 9 - Related articles - BL Direct - All 4 versions
OA Roges, M Baron, A Philis-Tsimikas - Expert Opin. Investig. Drugs, 2005 - informahealthcare.com The incretin effect is a phenomenon in which enteral glucose administration
provokes greater insulin secretion than intravenous administration. The main
incretins, glucose-dependent insulinotropic peptide and glucagon-like pep- ... Cited by 8 - Related articles - BL Direct - All 4 versions
GS Jeha, RA Heptulla - Pediatric Diabetes, 2006 - interscience.wiley.com Abstract: Recent studies in adult patients with type 1 diabetes mellitus (T1DM)
and T2DM have examined the potential utility, benefits, and side effects of
agents that augment insulin secretion after oral ingestion of nutrients in ... Cited by 7 - Related articles - BL Direct - All 3 versions
NE Mikhail - Endocrine Practice, 2006 - AACE Defective insulin secretion and insulin resistance con- tribute independently to
the development of type 2 dia- betes (1). In addition, type 2 diabetes is
generally charac- terized by inappropriately elevated plasma fasting and ... Cited by 6 - Related articles - BL Direct - All 2 versions
